Alpha-2B receptor agonist and anticonvulsant compositions for treatng chronic pain

Details for Australian Patent Application No. 2007337089 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2007337089

PCT Pub. Number WO2008/079720

Priority 60/871,716 22.12.06 US

Filing date 13 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/195 (2006.01)

A61K 31/197 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4174 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079720 Priority application(s): WO2008/079720

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337093-Improved diffuse light extended surface area water-supported photobioreactor

2007337088-Pyrimidine kinase inhibitors